Sophie Boutaud de la Combe, Director of Office of Public Information and Communication at the International Atomic Energy Agency (IAEA), visited Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. on August 29, 2024, in Shenzhen, South China’s Guangdong Province, a pioneer of China’s reform and opening-up.

The IAEA official learned about China’s medical applications of nuclear technology during her visit. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. has focused on innovations in isotopes and the pharmaceutical industry for many years. The company is engaged in the research, development, production, and sales of diagnostic breath test drugs and related detection instruments for Helicobacter pylori infections. Its products cover 32 provinces and cities in China and are provided to 82 countries and regions worldwide. Photos: Chen Tao/GT